Diagonal Therapeutics
Series BDiagonal Therapeutics is a privately held company based in United States, founded in 2022. The latest disclosed round is Series B ($125m), dated Jan 08, 2026. Institutional investors on record include Lightspeed Venture Partners.
United States · EST 2022
What is Diagonal Therapeutics?
Diagonal Therapeutics is a privately held company based in United States, founded in 2022. The latest disclosed round is Series B ($125m), dated Jan 08, 2026. Institutional investors on record include Lightspeed Venture Partners. Developer of antibody therapeutics for the treatment of rare diseases. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
Which funds backed Diagonal Therapeutics?
Who invested in Diagonal Therapeutics?
Funds on the dated round table. Open a name to read the fund card.
| Investor | Round | Amount | Date |
|---|---|---|---|
| Lightspeed Venture Partners | Series B | $125m | Jan 08, 2026 |
What do founders ask about Diagonal Therapeutics?
What is Diagonal Therapeutics?
Diagonal Therapeutics is a privately held company based in United States, founded in 2022. The latest disclosed round is Series B ($125m), dated Jan 08, 2026. Institutional investors on record include Lightspeed Venture Partners. Developer of antibody therapeutics for the treatment of rare diseases. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
What was Diagonal Therapeutics's last funding round?
Diagonal Therapeutics's latest disclosed round is Series B at $125m (Jan 08, 2026).
Who invested in Diagonal Therapeutics?
Diagonal Therapeutics has 1 institutional investors on this page, including Lightspeed Venture Partners.
How does CrackTheDeck cover Diagonal Therapeutics?
This startup card lists dated rounds and linked fund profiles so founders can see who is already in the cap table before a pitch.
How is this page compiled?
Round, amount, and investor names on the Diagonal Therapeutics card come from dated financings linked to fund profiles in CrackTheDeck. Empty fields mean the figure was not in those records. Updated Aug 2026.